Gianpietro Dotti, MD, is a Professor for the Department of Microbiology and Immunology and the Director of the Cellular Immunotherapy Program at Lineberger Cancer Center at The University of North Carolina at Chapel Hill. Dr. Dotti’s specializes in hematology and immunology. Since 2000, he has used his background in science and medicine to explore the use gene-modified T cells to treat hematologic malignancies, including lymphoma and leukemia, and solid tumors. His focus is primarily chimeric antigen receptor (CAR) T cell therapy that redirect the antigen specificity of T cells and strategies to overcome tumor inhibitory mechanisms.